In force Publication date 30 Jul 19

Pharmacokinetics of inhaled salmeterol alone or in combination with fluticasone and investigation of the role of CYP3A4 and P-gp polymorphisms

Resource description

Project Title: Pharmacokinetics of inhaled salmeterol alone or in combination with fluticasone and investigation of the role of CYP3A4 and P-gp polymorphisms

Researchers: Michael Petrou (University of Nicosia, Nicosia, Cyprus; Cyprus Anti-Doping Authority, Cyprus) and Constantinos Pistos (University of Pennsylvania, USA)

Year accepted: 2012

Summary: The main aim of the present study was to contribute to the development of a urinary threshold level to allow anti-doping organisations to differentiate between the permitted therapeutic use of salmeterol and its misuse in sport.

Download options

Available in 1 language.